American CryoStem Announces Asset Sale
March 24 2011 - 4:01PM
Marketwired
American CryoStem Corporation (PINKSHEETS: AMCY) announced today
that it has entered into an agreement to sell all of its assets to
R&A Productions, Inc. in exchange for a controlling interest in
R&A Productions, Inc. The transaction is subject, among other
conditions, to the completion of due diligence by both companies.
About American CryoStem: American CryoStem
Corporation (PINKSHEETS: AMCY) has developed and markets, a
proprietary core processing platform for Adipose (fat) Derived
Adult Stem Cells. The Company is in the business of collecting,
processing, and long term storage of adult stem cells, allowing
healthy individuals to privately preserve their stem cells for
future use in cell therapy at an affordable price. Adult Stem Cells
are currently being used in the emerging field of regenerative
medicine to potentially heal over an estimated 100+ diseases and
chronic conditions. Our proprietary platform provides a streamlined
and affordable method to process and cryopreserve Adipose Tissue
and Adipose Derived Stem Cells (ADSC) for autologous (self) use in
humans.
The Private Securities Litigation Reform Act of 1995 provides a
"safe harbor" for forward-looking statements. Certain of the
statements contained herein, which are not historical facts, are
forward-looking statements with respect to events, the occurrence
of which involve risks and uncertainties. These forward-looking
statements may be impacted, either positively or negatively, by
various factors. Information concerning potential factors that
could affect the Company is detailed from time to time in the
Company's reports filed with the Securities and Exchange
Commission.
For More Information, contact: Investor Relations American
CryoStem Corporation 188 East Bergen Place, Suite 204 Red Bank, NJ
07701 Phone: 732-747-1007 Fax: 732-747-7782
www.americancryostem.com Email Contact
ACS Global (CE) (USOTC:AMCY)
Historical Stock Chart
From Apr 2024 to May 2024
ACS Global (CE) (USOTC:AMCY)
Historical Stock Chart
From May 2023 to May 2024